Average Ratings 0 Ratings
Average Ratings 0 Ratings
Description
EVIDENS is an advanced AI platform that facilitates the discovery of digital cohorts, enhances research capabilities, promotes collaboration, and enables the sharing of insights across extensive hospital data sets. With the ability to swiftly annotate and convert your data into AI-compatible formats, users can efficiently filter populations by various clinical outcomes or demographic factors. The platform allows for limitless keyword filtering by training AI models to perform targeted searches. Furthermore, users can explore and establish criteria for cohort identification with the support of intelligent AI tools. Training AI models to automate the analysis process and categorize data into distinct groups can be done quickly and efficiently. The platform outputs AI-ready cohorts to facilitate the testing of clinical hypotheses in research studies. Users can effortlessly monitor the status and tasks related to all their projects and collaborators, while also being able to observe and engage with activities aligned with their research interests. Additionally, collaborative tools are provided to enable simultaneous efforts in creating, training, and validating AI models, fostering a productive research environment. Ultimately, EVIDENS streamlines the entire research process, making it more efficient and effective for all involved.
Description
We are a biotechnology firm in the clinical stage, dedicated to unraveling biological complexities through the integration of cutting-edge innovations spanning biology, chemistry, automation, machine learning, and engineering, all aimed at revolutionizing drug discovery. Our approach allows for enhanced precision in biological manipulation with advanced techniques like CRISPR genome editing and synthetic biology. We also achieve reliable automation for intricate laboratory processes at an unprecedented scale through the use of sophisticated robotics. By employing neural network architectures, we conduct iterative analyses and draw insights from extensive, intricate datasets generated in-house. Furthermore, we are boosting the adaptability of high-performance computing capabilities through cloud-based solutions. Our initiative harnesses new technologies to foster continuous learning cycles around our datasets, establishing us as a next-generation biopharmaceutical enterprise. This is achieved through a harmonious integration of hardware, software, and data, all dedicated to the industrialization of drug discovery. We are transforming the conventional drug discovery pipeline and boast one of the most extensive, diverse, and in-depth pipelines among technology-driven drug discovery companies. Ultimately, our mission is to enhance the efficiency and effectiveness of drug development, paving the way for breakthrough therapies.
API Access
Has API
API Access
Has API
Integrations
No details available.
Integrations
No details available.
Pricing Details
No price information available.
Free Trial
Free Version
Pricing Details
No price information available.
Free Trial
Free Version
Deployment
Web-Based
On-Premises
iPhone App
iPad App
Android App
Windows
Mac
Linux
Chromebook
Deployment
Web-Based
On-Premises
iPhone App
iPad App
Android App
Windows
Mac
Linux
Chromebook
Customer Support
Business Hours
Live Rep (24/7)
Online Support
Customer Support
Business Hours
Live Rep (24/7)
Online Support
Types of Training
Training Docs
Webinars
Live Training (Online)
In Person
Types of Training
Training Docs
Webinars
Live Training (Online)
In Person
Vendor Details
Company Name
Imagia
Founded
2015
Country
Canada
Website
imagia.com/our-platform/
Vendor Details
Company Name
Recursion
Country
United States
Website
www.recursion.com
Product Features
Artificial Intelligence
Chatbot
For Healthcare
For Sales
For eCommerce
Image Recognition
Machine Learning
Multi-Language
Natural Language Processing
Predictive Analytics
Process/Workflow Automation
Rules-Based Automation
Virtual Personal Assistant (VPA)